1. Home
  2. RXRX vs EVT Comparison

RXRX vs EVT Comparison

Compare RXRX & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • EVT
  • Stock Information
  • Founded
  • RXRX 2013
  • EVT 2003
  • Country
  • RXRX United States
  • EVT United States
  • Employees
  • RXRX N/A
  • EVT N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • EVT Finance Companies
  • Sector
  • RXRX Health Care
  • EVT Finance
  • Exchange
  • RXRX Nasdaq
  • EVT Nasdaq
  • Market Cap
  • RXRX 2.0B
  • EVT 1.8B
  • IPO Year
  • RXRX 2021
  • EVT N/A
  • Fundamental
  • Price
  • RXRX $6.97
  • EVT $24.87
  • Analyst Decision
  • RXRX Buy
  • EVT
  • Analyst Count
  • RXRX 6
  • EVT 0
  • Target Price
  • RXRX $9.40
  • EVT N/A
  • AVG Volume (30 Days)
  • RXRX 4.1M
  • EVT 121.5K
  • Earning Date
  • RXRX 11-06-2024
  • EVT 01-01-0001
  • Dividend Yield
  • RXRX N/A
  • EVT 7.72%
  • EPS Growth
  • RXRX N/A
  • EVT N/A
  • EPS
  • RXRX N/A
  • EVT N/A
  • Revenue
  • RXRX $49,635,000.00
  • EVT N/A
  • Revenue This Year
  • RXRX $57.90
  • EVT N/A
  • Revenue Next Year
  • RXRX $35.23
  • EVT N/A
  • P/E Ratio
  • RXRX N/A
  • EVT N/A
  • Revenue Growth
  • RXRX N/A
  • EVT N/A
  • 52 Week Low
  • RXRX $5.04
  • EVT $18.70
  • 52 Week High
  • RXRX $15.74
  • EVT $23.82
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 56.62
  • EVT 62.36
  • Support Level
  • RXRX $6.22
  • EVT $23.95
  • Resistance Level
  • RXRX $6.90
  • EVT $24.52
  • Average True Range (ATR)
  • RXRX 0.32
  • EVT 0.26
  • MACD
  • RXRX 0.04
  • EVT -0.00
  • Stochastic Oscillator
  • RXRX 90.64
  • EVT 97.05

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.

Share on Social Networks: